Propranolol for infantile haemangiomas: certain chances, potential risks

Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol

(2014) L. Solman et al.   ARCHIVES OF DISEASE IN CHILDHOOD

The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action

(2014) Y. Ji et al.   BRITISH JOURNAL OF DERMATOLOGY

Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas

(2014) A. Langley et al.   BRITISH JOURNAL OF DERMATOLOGY

Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study

(2014) Álvaro Abarzúa-Araya et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review

(2013) Ann L. Marqueling et al.   PEDIATRIC DERMATOLOGY

Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol

(2012) E. Pope et al.   BRITISH JOURNAL OF DERMATOLOGY

Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions

(2012) D.J.J. Hermans et al.   BRITISH JOURNAL OF DERMATOLOGY

Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

(2012) B. A. Drolet et al.   PEDIATRICS

Recurrence of Infantile Hemangiomas Treated with Propranolol

(2011) Lorea Bagazgoitia et al.   PEDIATRIC DERMATOLOGY

A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

(2011) M. Hogeling et al.   PEDIATRICS

 -Adrenergic Blockade during Memory Retrieval in Humans Evokes a Sustained Reduction of Declarative Emotional Memory Enhancement

(2010) M. C. W. Kroes et al.   JOURNAL OF NEUROSCIENCE

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE